Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial

Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T05:15:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. No changes to study details or page content are introduced.
    Difference
    0.0%
    Check dated 2026-03-22T09:21:27.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added to the site; it replaces the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T20:00:45.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1; no study content, eligibility criteria, or user-facing information appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T11:09:03.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page shows a minor site version update: Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T06:58:41.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with a new Revision: v3.4.0; removed the older lowercase/alternate labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T01:43:27.000Z thumbnail image

Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.